Among baseline tumor characteristics determined at initial biopsy, progesterone receptor expression was associated with EFS, with higher risk of relapse in patients with PR- tumors (HR = 3.25, log-rank P < 0.01; Fig. 1). Here, PGR is linked to neoplasm.